Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Aronstein currently holds 7,507,827 shares of AngioGenex, Inc. (AGGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Aronstein has been a net buyer of AGGX stock. They have purchased $200.0K and sold $0 worth of shares.
Michael Aronstein's most recent insider trade was on Aug 31, 2021, when they sold 750,000 shares at $0.00 per share.
Michael Aronstein serves as Executive at AngioGenex, Inc. (AGGX). They have executed 9 insider transactions totaling $200.0K over their tenure at the company.
Michael Aronstein holds the position of Executive at AngioGenex, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Michael Aronstein has shown a buying trading pattern, with $200.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Aronstein was on Oct 8, 2020, when they purchased $555.5M worth of AGGX shares. This transaction involved 55,555 shares at $10000.00 per share.
Michael Aronstein currently owns 7,507,827 shares of AngioGenex, Inc. (AGGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Aronstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Aronstein has 9 Form 4 filings on record as an insider at AngioGenex, Inc..
Set alerts for Michael Aronstein and 40,000+ other insiders.